Board of Directors

Se Hwan Yang, Ph.D - CEO
  • Experience in diverse field such as R&D, BD, finance, operations etc. in a growth company
  • Head of Development division, Genexine, Inc.
  • Head of R&D Center, Genexine, Inc.
  • Research fellow, Pasteur Institute
Richard Kang, Ph.D - COO
  • Experience in Management, Operation, R&D, Clinical Development and Business Development in Bio/Pharma companies
  • CEO of JK BioPharma Solutions, Inc
  • Former visiting fellow, NIH
  • Research staff in the University of Edinburgh, UK
Junghee Lim - CFO
  • Experience in Biotech venture investment
  • CIO of Intervest global pharmafund
  • Head of Strategic planning, IsuAbxis, Inc.
Jae Joon Kim
  • Currently a Director of the Venture Investment Division of Korea-based Mirae Asset Venture Investment
  • Has successfully listed over 16 companies on the NASDAQ, KOSDAQ and KONEX stock market exchanges, and manages an equity investment portfolio comprised of more than 50 biotech/pharma companies worldwide.
  • Experience in R&D and Investment in biopharmaceutical and medical diagnostics companies
  • Research associate at Macrogen
You Suk Suh, Ph.D
  • Experience in Development of Therapeutic Vaccines for Infectious Diseases
  • Currently CEO, Head of R&D division, Genexine, Inc.
  • Scientific Staff in German Primate Center (2002-2006)
  • Research Fellow in Alexander-von-Humboldt foundation (2004-2005)
Jae Chan Park, Ph.D
  • Currently Executive Vice President, Head of Business Division, Genexine
  • Senior Vice President & Managing Director, Bio R&D Center, Samsung Advanced Institute of Technology(SAIT), Samsung Electronics, Korea (1998-2014)
  • Director, Hanhyo Institute of Technology, Korea (1994 –1997)
  • Senior Research Investigator, G. D. Searle , USA (1991 –1994)